Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis of Nonclassical Quinazolinone Antifolates as Thymidylate Synthase Inhibitors and Their Antitumor Activity In Vitro

  • Baek, Du-Jong (Department of Chemistry, College of Natural Science, Sangmyung University) ;
  • Kang, Tae-Beom (Department of Chemistry, College of Natural Science, Sangmyung University) ;
  • Kim, Hyun-Ju (Research Laboratory, R & D Division, Choongwae Pharma Co.)
  • Published : 2004.12.20
Download PDF
⟨ Previous Next ⟩

Abstract

Nonclassical quinazolinone analogs I, II, and III, in which the glutamic acid moiety of the classical antifolates is substituted by phenylglycine, phenylalanine or aminobenzoic acid and their methyl esters, were synthesized and evaluated as lipophilic inhibitors of thymidylate synthase (TS). The target compounds were generally potent inhibitors of L. casei and human TS with $IC_{50}$ values within the narrow range of 0.2-10 ${\mu}$M and 0.003-0.03 ${\mu}$M, respectively. Further, most of the target compounds showed cytotoxicity against tumor cell lines of murine and human origin with $IC_{50}$ values of as low as 0.050 ${\mu}$M. Substitution of another hydroxyl or carboxylic acid/ester group at the phenyl ring further increased the potency of TS inhibition and cell growth inhibition. Most effective were compounds If and Ic in which extra carboxylic acid/ester was present at the phenyl ring with nanomolar $IC_{50}$ values of 0.0044 and 0.0093 ${\mu}$M against human TS and submicromolar cytotoxic growth inhibition against all four tumor cell lines.

Keywords

References

  1. Santi, D. V. J. Med. Chem. 1980, 23, 103. https://doi.org/10.1021/jm00176a001
  2. Johnston, P. G.; Drake, J. C.; Steinberg, S. M.; Allegra, C. J.Biochem. Pharmacol. 1983, 45, 2483. https://doi.org/10.1016/0006-2952(93)90230-T
  3. Takemura, Y.; Jackman, A. L. Anti-Cancer Drugs 1997, 8, 3. https://doi.org/10.1097/00001813-199701000-00001
  4. Walton, M. I.; Gibson, W.; Aherne, G. W.; Lawrence, N.;Stephens, T. C.; Smith, M. N.; Jackman, A. L. J. Pharmacol. Exp.Ther. 1996, 277, 909.
  5. Johnston, P. G.; Liang, C. M.; Henry, S.; Chabner, B. A.; Allegra,C. J. Cancer Res. 1991, 51, 6668.
  6. Jackman, A. L.; Kimbell, R.; Brown, M.; Brunton, L.; Harrap, K.R.; Wardleworth, J. M.; Boyle, F. T. Adv. Exp. Med. Biol. 1994,370, 185.
  7. Jones, T. R.; Calvert, A. H.; Jackman, A. L.; Brown, S. J.; Jones,M.; Harrap, K. R. Europ. J. Cancer 1981, 17, 11. https://doi.org/10.1016/0014-2964(81)90206-1
  8. Calvert, A. H.; Alison, D. L.; Harland, S. J.; Robinson, B. A.;Jackman, A. L.; Jones, T. R.; Newell, D. R.; Siddik, Z. H.;Wiltshaw, E.; McElwain, T. J.; Smith, I. E.; Harrap, K. R. J. Clin.Oncol. 1986, 4, 1245.
  9. Newell, D. R.; Alison, D. L.; Calvert, A. H.; Harrap, K. R.;Jarman, M.; Jones, T. R.; Manteuffel-Cymborowska, M.;O'Connor, P. Cancer Treat. Rep. 1986, 70, 971.
  10. Marsham, P. R.; Hughes, L. R.; Jackman, A. L.; Hayter, A. J.;Oldfield, J.; Wardleworth, J. M.; Bishop, J. A. M.; O'Connor, B.M.; Calvert, A. H. J. Med. Chem. 1991, 34, 1594. https://doi.org/10.1021/jm00109a011
  11. Hardy, L. W.; Finer-Moore, J. S.; Montfort, W. R.; Jones, M. O.;Santi, D. V.; Stroud, R. M. Science 1987, 235, 449.
  12. Sikora, E.; Jackman, A. L.; Newell, D. R.; Calvert, A. H.Biochem. Pharmacol. 1988, 37, 4047. https://doi.org/10.1016/0006-2952(88)90094-9
  13. Webber, S. E.; Bleckman, T. M.; Attard, J.; Deal, J. G.;Kathardekar, V.; Welsh, K. M.; Webber, S.; Janson, C. A.;Matthews, D. A.; Smith, W. W.; Freer, S. T.; Jordan, S. R.;Bacquet, R. J.; Howland, E. F.; Booth, C. L. J.; Ward, R. W.;Hermann, S. M.; White, J.; Morse, C. A.; Hilliard, J. A.; Bartlett,C. A. J. Med. Chem. 1993, 36, 733. https://doi.org/10.1021/jm00058a010
  14. Webber, S.; Bartlett, C. A.; Boritzki, T. J.; Hilliard, J. A.;Howland, E. F.; Johnston, A. L.; Kosa, M.; Margosiak, S. A.;Morse, C. A.; Shetty, B. A. Cancer Chemother. Pharmacol. 1996,37, 509. https://doi.org/10.1007/s002800050422
  15. Rafi, I.; Taylor, G. A.; Balmanno, K.; Calvete, J. A.; Newell, D.R.; Lind, M. J.; Calvert, A. H. Proc. Am. Assoc. Cancer Res. 1994,35, 306.
  16. Chakraborty, T. K.; Reddy, G. V.; Hussain, K. A. Tetrahedron Lett.1991, 32, 7597. https://doi.org/10.1016/0040-4039(91)80544-G
  17. Wahba, A. J.; Friedkin, M. J. Biol. Chem. 1961, 236, PC11.
  18. Lomax, M. I. S.; Greenberg, G. R. J. Biol. Chem. 1967, 242, 109.
  19. Mosmann, T. J. Immunol. Methods 1983, 65, 55. https://doi.org/10.1016/0022-1759(83)90303-4
  20. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. https://doi.org/10.1021/jo00408a041

Cited by

  1. Synthesis and antimicrobial activities of 2-azetidinyl-4-quinazolinone derivatives of diclofenac analogue vol.20, pp.4, 2011, https://doi.org/10.1007/s00044-010-9345-y
  2. Synthesis of Nonclassical Quinazolinone Antifolates as Thymidylate Synthase Inhibitors and Their Antitumor Activity in vitro. vol.36, pp.24, 2005, https://doi.org/10.1002/chin.200524214